Dimensional Fund Advisors’s ArriVent BioPharma AVBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.8M Buy
324,998
+113,489
+54% +$3.48M ﹤0.01% 2276
2026
Q2
$7.35M Buy
211,509
+84,984
+67% +$2.51M ﹤0.01% 2428
2026
Q1
$2.92M Buy
126,525
+111,782
+758% +$2.52M ﹤0.01% 2627
2025
Q4
$297K Buy
14,743
+585
+4% +$12.2K ﹤0.01% 3045
2025
Q3
$261K Buy
+14,158
New +$278K ﹤0.01% 3086

Other funds holding AVBP

Dimensional Fund Advisors's AVBP Position: Q3 2026 in Review

Dimensional Fund Advisors increased its ArriVent BioPharma (AVBP) stake by 54% in Q3 2026, buying an estimated $3.48M and bringing the position to 324,998 shares worth $9.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2276.

Dimensional Fund Advisors first reported a position in AVBP in Q3 2025 and has held it in 5 quarters since. 153 funds tracked by Wall St. Rank hold AVBP as of Q3 2026.

  • Dimensional Fund Advisors held 324,998 shares of ArriVent BioPharma worth $9.8M as of Q3 2026.
  • Dimensional Fund Advisors bought 113,489 ArriVent BioPharma shares in Q3 2026, an estimated $3.48M.
  • ArriVent BioPharma made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2276 holding.
  • Dimensional Fund Advisors first reported a position in ArriVent BioPharma in Q3 2025 and has held it in 5 quarters since.
  • 153 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.